Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Adlai M Schuler"'
Autor:
Johann F Coetzee, Drew R Magstadt, Pritam K Sidhu, Lendie Follett, Adlai M Schuler, Adam C Krull, Vickie L Cooper, Terry J Engelken, Michael D Kleinhenz, Annette M O'Connor
Publikováno v:
PLoS ONE, Vol 14, Iss 12, p e0219104 (2019)
Although 90% of BRD relapses are reported to receive retreatment with a different class of antimicrobial, studies examining the impact of antimicrobial selection (i.e. bactericidal or bacteriostatic) on retreatment outcomes and the emergence of antim
Externí odkaz:
https://doaj.org/article/56e8914cd5f74406a243846fa1c40a8a
Autor:
Adam C. Krull, Vickie L. Cooper, Drew R. Magstadt, Adlai M. Schuler, Terry J. Engelken, Annette M. O'Connor, Johann F. Coetzee
Publikováno v:
Journal of Veterinary Diagnostic Investigation. 30:99-104
Bovine respiratory disease is the most costly disease facing the cattle industry. Increasing resistance to antimicrobial treatment has been presented as a significant contributing factor, often through summarized susceptibility testing data. We asses
Autor:
Drew R. Magstadt, Vickie L. Cooper, Adam C. Krull, Adlai M. Schuler, Annette M. O'Connor, Lendie Follett, Terry J. Engelken, Pritam K. Sidhu, Johann F. Coetzee
Although 90% of BRD relapses are reported to receive retreatment with a different class of antimicrobial, studies examining the impact of antimicrobial selection (i.e. bactericidal or bacteriostatic) on retreatment outcomes and the emergence of antim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae264919e5138b0ad08e7035c2524fdc
https://doi.org/10.1101/675066
https://doi.org/10.1101/675066
Autor:
Vickie L. Cooper, Michael D. Kleinhenz, Terry J. Engelken, Drew R. Magstadt, Lendie Follett, Pritam K. Sidhu, Adam C. Krull, Johann F. Coetzee, Adlai M. Schuler, Annette M. O'Connor
Publikováno v:
PLoS ONE
PLoS ONE, Vol 14, Iss 12, p e0219104 (2019)
PLoS ONE, Vol 14, Iss 12, p e0219104 (2019)
Although 90% of BRD relapses are reported to receive retreatment with a different class of antimicrobial, studies examining the impact of antimicrobial selection (i.e. bactericidal or bacteriostatic) on retreatment outcomes and the emergence of antim